000 01613 a2200433 4500
005 20250514075813.0
264 0 _c20030916
008 200309s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.11616
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShasha, Daniel
245 0 0 _aOnce-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
_h[electronic resource]
260 _bCancer
_cSep 2003
300 _a1072-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aEpoetin Alfa
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHematinics
_xadministration & dosage
650 0 4 _aHemoglobins
_xanalysis
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aQuality of Life
650 0 4 _aRadiotherapy
_xadverse effects
650 0 4 _aRecombinant Proteins
700 1 _aGeorge, Martine J
700 1 _aHarrison, Louis B
773 0 _tCancer
_gvol. 98
_gno. 5
_gp. 1072-9
856 4 0 _uhttps://doi.org/10.1002/cncr.11616
_zAvailable from publisher's website
999 _c12712602
_d12712602